Gertjan J L Kaspers Selected Research

Stem Cell Transplantation

6/2012	Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors.
9/2010	A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gertjan J L Kaspers Research Topics

Disease

66	Neoplasms (Cancer) 10/2023 - 02/2003
32	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2021 - 01/2005
31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 05/2003
24	Diffuse Intrinsic Pontine Glioma 06/2021 - 02/2013
14	Leukemia 01/2023 - 11/2005
11	Glioma (Gliomas) 06/2022 - 12/2011
9	Brain Neoplasms (Brain Tumor) 06/2022 - 02/2003
7	Peripheral Nervous System Diseases (PNS Diseases) 12/2023 - 12/2020
6	Hypersensitivity (Allergy) 08/2023 - 05/2013
6	Fatigue 12/2022 - 09/2011
5	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 06/2009
5	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 06/2003
4	Medulloblastoma 11/2020 - 02/2003
3	Brain Stem Neoplasms (Brain Stem Tumor) 01/2021 - 01/2014
3	Residual Neoplasm 12/2014 - 10/2005
3	Carcinoma (Carcinomatosis) 05/2014 - 03/2003
3	Osteosarcoma (Osteogenic Sarcoma) 04/2011 - 03/2005
2	Disease Progression 06/2021 - 10/2019
2	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2017
2	Infections 01/2019 - 08/2015
2	Acute Promyelocytic Leukemia 01/2018 - 09/2017
2	Retinoblastoma (Glioblastoma, Retinal) 01/2017 - 01/2016
2	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2016 - 07/2014
2	Carcinogenesis 05/2015 - 02/2009
2	Ependymoma 07/2014 - 12/2011
2	Neoplasm Metastasis (Metastasis) 04/2011 - 01/2008
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2008 - 01/2006
1	Malnutrition (Nutritional Deficiencies) 07/2023
1	Cardiotoxicity 12/2022
1	Chronic Renal Insufficiency 11/2022
1	Hyperthyroidism 11/2022
1	Albuminuria 11/2022
1	Body Weight (Weight, Body) 10/2022
1	Hypertension (High Blood Pressure) 09/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2022
1	Proteinuria 06/2022
1	Sleep Wake Disorders 02/2022

Drug/Important Bio-Agent (IBA)

23	dipinacoline glutamateIBA 06/2021 - 02/2013
10	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2008
8	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 12/2020
7	Asparaginase (Elspar)FDA Link 01/2019 - 01/2005
6	Methotrexate (Mexate)FDA LinkGeneric 07/2021 - 07/2005
6	Bortezomib (Velcade)FDA Link 01/2021 - 12/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2011
5	Proteasome InhibitorsIBA 01/2021 - 12/2013
5	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 09/2012
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 12/2004
5	multidrug resistance-associated protein 1IBA 01/2019 - 03/2003
5	Folic Acid (Vitamin M)FDA LinkGeneric 04/2016 - 03/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 02/2008
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 12/2013
4	Histones (Histone)IBA 01/2021 - 01/2017
4	Phosphotransferases (Kinase)IBA 12/2020 - 10/2005
4	GlucocorticoidsIBA 03/2020 - 10/2007
3	RNA Splicing FactorsIBA 01/2023 - 05/2015
3	AnthracyclinesIBA 12/2022 - 05/2017
3	CreatinineIBA 11/2022 - 08/2011
3	Bevacizumab (Avastin)FDA Link 06/2021 - 01/2016
3	Gemcitabine FDA Link 01/2020 - 11/2017
3	MicroRNAs (MicroRNA)IBA 07/2016 - 06/2014
3	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2015 - 09/2012
2	Gemtuzumab (Mylotarg)FDA Link 01/2023 - 05/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 05/2017
2	RNA Precursors (Precursor, mRNA)IBA 12/2020 - 05/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 12/2004
2	Thymidylate SynthaseIBA 01/2019 - 07/2005
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 06/2006
2	89Zr-bevacizumabIBA 01/2018 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2005
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018 - 02/2013
2	Alkylating AgentsIBA 02/2017 - 05/2012
2	folylpolyglutamate synthetaseIBA 04/2016 - 01/2016
2	Cytotoxins (Cytolysins)IBA 05/2015 - 12/2011
2	Messenger RNA (mRNA)IBA 06/2014 - 09/2010
2	Temozolomide (Temodar)FDA LinkGeneric 06/2014 - 01/2014
2	PR-957IBA 01/2014 - 12/2013
2	carfilzomibIBA 01/2014 - 12/2013
2	Core Binding Factors (Core-Binding Factor)IBA 10/2011 - 03/2011
2	CCAAT-Enhancer-Binding ProteinsIBA 03/2011 - 01/2005
2	fludarabineIBA 01/2006 - 12/2004
1	Immunoglobulin G (IgG)IBA 08/2023
1	nuclear pore complex protein 98IBA 01/2023
1	Dexrazoxane (Zinecard)FDA LinkGeneric 12/2022
1	Ifosfamide FDA LinkGeneric 11/2022
1	AlbuminsIBA 11/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Cisplatin (Platino)FDA LinkGeneric 11/2022
1	TubulinIBA 10/2022
1	Aurora Kinase AIBA 06/2022
1	AntigensIBA 08/2021

Therapy/Procedure

35	Therapeutics 01/2023 - 10/2005
19	Drug Therapy (Chemotherapy) 07/2023 - 02/2003
14	Radiotherapy 11/2022 - 02/2003
12	Aftercare (After-Treatment) 12/2022 - 11/2010
4	Complementary Therapies (Alternative Medicine) 01/2023 - 01/2016
2	Injections 02/2023 - 12/2020
2	Immunotherapy 08/2021 - 01/2021
2	Stem Cell Transplantation 06/2012 - 09/2010
1	Remission Induction 08/2023
1	Nephrectomy 11/2022